Welcome to the Cannabis Countdown. In This Week’s Edition, We Recap and Countdown the Top 10 Marijuana and Psychedelic Stock News Stories for the Week of September 7th – 13th, 2020.
Without further ado, let’s get started.
* Yahoo Finance readers, please click here to view full article.
10. This UK-Based Psychedelics Company is Ready to Go Public on the NASDAQ
In Yet Another Sign That Psychedelics Are Making Their Way Into the Mainstream, Compass Pathways Has Filed for its Initial Public Offering (IPO) on the NASDAQ Stock Exchange
The London-based Compass Pathways, which will trade under the ticker symbol ‘CMPS,’ is backed by some serious heavyweights, including lead investor Christian Angermayer and well-known Silicon Valley tech billionaire Peter Thiel.
READ FULL COMPASS PATHWAYS ARTICLE
9. Want to Lose $1.8 Billion? Invest in Aurora Cannabis Stock
On Tuesday, Aurora Announced a Potentially Massive 1.8 Billion Write-Down for Q4
Simultaneously, Aurora Cannabis ACB announced it has chosen a new CEO, its Chief Commercial Officer Miguel Martin. The market reacted with shock, sending ACB Stock down 12% before recovering.
READ FULL AURORA CANNABIS ARTICLE
8. Psychedelics Company Havn Life Sciences Debuts on CSE
The Company is Led By Co-CEOs Susan Chapelle and Tim Moore, the Former CEO of Cannabis Company Green Growth Brands
Havn Life Sciences HAVN, a recently-formed Psychedelics company, announced on Tuesday its debut on the Canadian Securities Exchange (CSE) under the symbol HAVN.
7. CIBC: Cronos Group CEO Switch Up is “Somewhat Surprising”
In a Note from CIBC, Analyst John Zamparo Comments, “CEO Transition – Doubling Down On Consumer Focus”
This past week, Cronos Group CRON announced that its Board of Directors has appointed Kurt Schmidt as President and Chief Executive Officer of the Company and that Mike Gorenstein has been appointed Executive Chairman. Mike Gorenstein served as the Chairman, President, and CEO of Cronos since 2016.
READ FULL CRONOS GROUP ARTICLE
6. 3 Psychedelic Stocks to Buy for HUGE Gains in the Shroom Boom
Psychedelic Drugs Are Losing Their Negative Stigma, Paving the Way for Major Gains in Psychedelic Stocks
What will drive this Shroom Boom of the 2020s? The same things that drove the cannabis boom of the 2010s. Changing science. Changing consumer attitudes. And, changing laws. With that in mind, some of the best Psychedelic Stocks to buy for potentially huge gains are MindMed MMEDF, Champignon Brands SHRMF and Revive Therapeutics RVVTF.
READ FULL PSYCHEDELIC STOCKS ARTICLE
5. The 3 Most Exciting Pot Stocks You’re Overlooking
These Cannabis Stocks Aren’t Getting a Lot of Attention Yet, But They Soon Will Be
If you want truly exciting Pot Stocks that aren’t yet on many investors’ radars, then take a gander at these three Cannabis companies: TerrAscend TRSSF, Planet 13 PLNHF and Jushi Holdings JUSHF.
4. Havn Life Sciences Granted Section 56 Exemption to Begin Scientific Work With Psilocybin
Havn Life Will Develop Methods for Safe, Standardized, Quality- Controlled Production of Medical Compounds Extracted From the Psilocybe Spp. Mushroom
Havn Life Sciences HAVN announced that its wholly-owned subsidiary, HAVN Research Inc., was granted a Section 56 exemption by Health Canada, pursuant to which it now has the ability to possess certain amounts of pure Psilocybin for scientific purposes, specifically for the research and development of quality control methods.
3. Canopy Growth Launches Martha Stewart CBD Line
Initially, the Line Consists of Four Products Containing the Popular Substance
One of America’s top lifestyle gurus has taken the plunge into marijuana-related goods. Canopy Growth CGC announced in a press release that it has launched Martha Stewart CBD, a new line of comestibles infused with cannabidiol (CBD).
READ FULL CANOPY GROWTH ARTICLE
2. Why Investing in Psychedelic Medicine Could Be Better Than Cannabis
Psychedelic Companies Are Seeking FDA Approval to Develop Drugs to Treat Mental Health Disorders
The burgeoning Psychedelic sector is attracting attention from investors as more companies have gone public, and research has increased rapidly due to greater mainstream and government acceptance and decriminalization.
READ FULL PSYCHEDELICS INVESTING ARTICLE
1. 3 Top Marijuana Stocks to Buy in September
These Cannabis Stocks Have at Least Two Things in Common: A Focus on the U.S. Market and Tremendous Growth
Quite a few Cannabis Stocks that focus on the U.S. market have delivered fantastic performances in 2020. Some of them appear to be poised to keep the good times rolling. Here are three top marijuana stocks to buy in September: Green Thumb GTBIF, GrowGeneration GRWG and Innovative Industrial Properties IIPR.
READ FULL TOP MARIJUANA STOCKS ARTICLE
Photo by Roberto Valdivia on Unsplash
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
The Benzinga Cannabis Capital Conference is coming to Florida
The Benzinga Cannabis Capital Conference is returning to Florida, in a new venue in Hollywood, on April 16 and 17, 2024. The two-day event at The Diplomat Beach Resort will be a chance for entrepreneurs, both large and small, to network, learn and grow. Renowned for its trendsetting abilities and influence on the future of cannabis, mark your calendars – this conference is the go-to event of the year for the cannabis world.
Get your tickets now on bzcannabis.com – Prices will increase very soon!